Table 5.
Means ± SD for blood serum metabolites1 during and after the treatment period2.
Control (n = 5) | CLA (n = 5) | |||||||
---|---|---|---|---|---|---|---|---|
1 - 28 DIM | 29 - 56 DIM | 1 - 28 DIM | 29 - 56 DIM | |||||
Variable | mean | SD | mean | SD | mean | SD | mean | SD |
TB3, μmol/L | 7.01 | 4.52 | 3.58 | 0.74 | 4.51 | 0.73 | 3.10 | 0.70 |
Glucose, mmol/L | 3.40 | 0.11 | 3.53 | 0.06 | 3.47 | 0.28 | 3.53 | 0.19 |
NEFA4, μmol/L | 483 | 174 | 165 | 105 | 378 | 119 | 152 | 61.1 |
BHB5, mmol/L | 0.54 | 0.14 | 0.22 | 0.08 | 0.49 | 0.28 | 0.39 | 0.04 |
1Jugular blood samples were collected at week 0, 1, 2, 4, 6, 8. Values from week 0, 1, 2, 4 were calculated for 1 - 28 DIM, values from week 6 and 8 were calculated for 29 - 56 DIM.
2CLA supplemented timeframe: d 1 until d 28 of lactation; five primiparous cows received a special supplement including rumen-protected CLA (10 g c9,t11-CLA/day and t10,c12-CLA/day).
3total bilirubin.
4non-esterified fatty acids.
5betahydroxybutyrate.